Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Joan Salvador Russo-Cabrera
Observed names:
J.S. Russo-Cabrera,
Joan S. Russo-Cabrera
Institutions:
Research Institute Hospital 12 de Octubre,
Spanish National Cancer Research Centre,
Navarre Institute of Health Research,
Centro de Investigación Médica Aplicada,
Universidad de Navarra
Observed institutions:
Research Institute Hospital 12 de Octubre,
Spanish National Cancer Research Centre,
Navarre Institute of Health Research,
Centro de Investigación Médica Aplicada,
Universidad de Navarra
ORCID:
0000-0001-7517-8936
Observed ORCID:
0000-0001-7517-8936
OpenAlex ID:
A5011805428
Intratumoral injection of IL-12-encoding mRNA targeted to CSF1R and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure
2023
·
Claudia Augusta Di Trani
, Assunta Cirella
, et al.
·
Molecular Therapy — Nucleic Acids
·
35
PDF
Intracavitary adoptive transfer of IL-12 mRNA-engineered tumor-specific CD8 + T cells eradicates peritoneal metastases in mouse models
2022
·
Claudia Augusta Di Trani
, Assunta Cirella
, et al.
·
OncoImmunology
·
20
Omentum: Friend or foe in ovarian cancer immunotherapy?
2022
·
Ángela Bella
, Leire Arrizabalaga
, et al.
·
International review of cytology
·
17
Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)
2024
·
Amaya Lopez-Pascual
, Joan S. Russo-Cabrera
, et al.
·
Clinical Science
·
15
Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosis
2023
·
Ángela Bella
, Leire Arrizabalaga
, et al.
·
Journal for ImmunoTherapy of Cancer
·
13
PDF
Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
2025
·
Esther Redin
, Nerea Otegui
, et al.
·
Cancer Research
·
12
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis
2022
·
Ángela Bella
, Leire Arrizabalaga
, et al.
·
OncoImmunology
·
10
PDF
A human IgE bispecific antibody shows potent cytotoxic capacity mediated by monocytes
2022
·
Natasa Vukovic
, Samer Halabi
, et al.
·
Journal of Biological Chemistry
·
10
PDF
Efficacy of LCMV-based cancer immunotherapies is unleashed by intratumoral injections of polyI:C
2024
·
Celia Gomar
, Claudia Augusta Di Trani
, et al.
·
Journal for ImmunoTherapy of Cancer
·
8
PDF
Intraperitoneal administration of mRNA encoding interleukin-12 for immunotherapy in peritoneal carcinomatosis
2025
·
Leire Arrizabalaga
, Claudia Augusta Di Trani
, et al.
·
Journal of Nanobiotechnology
·
6
PDF
Tumor slice culture system for ex vivo immunotherapy studies
2024
·
Leire Arrizabalaga
, Joan Salvador Russo-Cabrera
, et al.
·
Methods in cell biology
·
6
1050P Sensitization to immunotherapy through manipulation of tumor transcription by lurbinectedin
2023
·
J.S. Russo-Cabrera
, S. Ponce Aix
, et al.
·
Annals of Oncology
·
5
PDF
Abstract 5837: Lurbinectedin-induced transcriptional reprogramming: A pathway to sensitise SCLC to immunotherapy
2025
·
Joan Salvador Russo-Cabrera
, Santiago Ponce-Aix
, et al.
·
Cancer Research
·
2
Supplementary Figure 7 from Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
2025
·
Esther Redin
, Nerea Otegui
, et al.
PDF
Supplementary Figure 3 from Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
2025
·
Esther Redin
, Nerea Otegui
, et al.
Supplementary Figure 4 from Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
2025
·
Esther Redin
, Nerea Otegui
, et al.
PDF
Supplementary Figure 5 from Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
2025
·
Esther Redin
, Nerea Otegui
, et al.
PDF
Supplementary Figure 2 from Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
2025
·
Esther Redin
, Nerea Otegui
, et al.
PDF
Data from Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
2025
·
Esther Redin
, Nerea Otegui
, et al.
Supplementary Tables from Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
2025
·
Esther Redin
, Nerea Otegui
, et al.
Supplementary Figure 9 from Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
2025
·
Esther Redin
, Nerea Otegui
, et al.
PDF
Supplementary Figure 6 from Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
2025
·
Esther Redin
, Nerea Otegui
, et al.
PDF
Supplementary Figure 1 from Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
2025
·
Esther Redin
, Nerea Otegui
, et al.
PDF
Supplementary Figure 8 from Dasatinib Remodels the Tumor Microenvironment and Sensitizes Small Cell Lung Cancer to Immunotherapy
2025
·
Esther Redin
, Nerea Otegui
, et al.
Show more works
View as search
Works count:
24
Citation count:
159
H-index:
8
I10-index:
8
Year
Topic
Type